[1]
Takazawa T,Mitsuhata H,Mertes PM, Sugammadex and rocuronium-induced anaphylaxis. Journal of anesthesia. 2016 Apr;
[PubMed PMID: 26646837]
[2]
Pei DQ,Zhou HM,Zhou QH, Grip strength can be used to evaluate postoperative residual neuromuscular block recovery in patients undergoing general anesthesia. Medicine. 2019 Jan;
[PubMed PMID: 30633170]
[3]
Murphy GS,Szokol JW,Marymont JH,Greenberg SB,Avram MJ,Vender JS, Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesthesia and analgesia. 2008 Jul;
[PubMed PMID: 18635478]
[4]
Yang T,Li Z,Jiang L,Wang Y,Xi X, Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis. Acta neurologica Scandinavica. 2018 Aug;
[PubMed PMID: 29845614]
Level 1 (high-level) evidence
[5]
McLean DJ,Diaz-Gil D,Farhan HN,Ladha KS,Kurth T,Eikermann M, Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications. Anesthesiology. 2015 Jun;
[PubMed PMID: 25919486]
[6]
Fortier LP,McKeen D,Turner K,de Médicis É,Warriner B,Jones PM,Chaput A,Pouliot JF,Galarneau A, The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. Anesthesia and analgesia. 2015 Aug;
[PubMed PMID: 25902322]
Level 2 (mid-level) evidence
[8]
Brull SJ,Kopman AF, Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology. 2017 Jan;
[PubMed PMID: 27820709]
[9]
Staals LM,Driessen JJ,Van Egmond J,De Boer HD,Klimek M,Flockton EA,Snoeck MM, Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex. Acta anaesthesiologica Scandinavica. 2011 Jul;
[PubMed PMID: 21574968]
[10]
Simonini A,Brogi E,Calevo MG,Carron M, Sugammadex for reversal of neuromuscular blockade in paediatric patients: a two-year single-centre retrospective study. Anaesthesia, critical care
[PubMed PMID: 30818070]
Level 2 (mid-level) evidence
[11]
Jahr JS,Miller JE,Hiruma J,Emaus K,You M,Meistelman C, Sugammadex: A Scientific Review Including Safety and Efficacy, Update on Regulatory Issues, and Clinical Use in Europe. American journal of therapeutics. 2015 Jul-Aug;
[PubMed PMID: 25299637]